Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00862368 · ClinicalTrials.gov registry record · Phase 3

Sustaining Smoking Cessation in Smokers With Kids With Asthma

A Phase 3 study, sponsored by The Miriam Hospital.

Completed
Registry status
Phase 3
Development phase
573
Enrollment target

NCT00862368 is a Phase 3 study that has completed, run by The Miriam Hospital. The registered enrollment target is 573 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00862368, a Phase 3 study, has completed, sponsored by The Miriam Hospital.

COMPLETED
Registry status
Phase 3
Development phase
573 participants
Enrollment target

Study Summary

Parents of Asthmatics Quit Smoking (PAQS-2) is a randomized controlled trial of a smoking cessation intervention for parents who smoke. Children had either a diagnosis of asthma (and an asthma emergency within the past 3 months) or were healthy (and had no medical conditions in the past 3 months). The study intervention aimed to help parents (or caregivers) quit smoking and reduce children's second hand smoke exposure. Participants received 2 home counseling sessions with asthma education (if they had a child with asthma), child wellness (if they had a healthy child) and smoking cessation counseling (including objective feedback on how much smoke the child was exposed to). Parents of children with asthma were then randomized into 2 groups; one group received 6 counseling phone calls focused on motivating smoking cessation and a second round of feedback on smoke exposure (Enhanced). The other groups received six calls focused on asthma (PAM asthma group) or child wellness (Healthy group). We had 2 primary aims. First, to explore the "teachable moment" we compared quit rates between the parents of children with asthma to the parents of healthy children. We hypothesized that the Asthma group would have significantly greater quit rates than the Healthy group and lower levels of environmental tobacco smoke in the home. We also hypothesized that parents who smoke and have children with asthma would have greater changes in the variables associated with teachable moment compared to parents who smoke and have a healthy child. --- The second primary aim focused on the parents of children with asthma. We assessed the effectiveness of adding telephone smoking cessation counseling to the 2 home counseling visits. For this, we compared the 2 groups of randomized subjects: those who received 6 counseling calls and feedback on smoke exposure (PAM-Enhanced) and those who received 6 counseling calls focused on asthma education (PAM-Asthma). We hypothesized that the PAM-Enhanced group

Interventions

  • BEHAVIORAL PAM
  • BEHAVIORAL PAM-Enhanced/Asthma Counseling Phone Calls
  • BEHAVIORAL Follow-Up Phone Calls - Child Wellness Topic

Trial Details

FieldValue
Enrollment Target 573 participants
Start Date 2005-10
Est. Completion 2011-12
Phase Phase 3

Sponsor

The Miriam Hospital

136 total trials

What the Registry Record Tells You About NCT00862368

The ClinicalTrials.gov registry entry for NCT00862368 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 573 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Miriam Hospital, which has 136 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which PAM is the first listed.

NCT00862368 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00862368 about?

NCT00862368 is a clinical study titled "Sustaining Smoking Cessation in Smokers With Kids With Asthma". Parents of Asthmatics Quit Smoking (PAQS-2) is a randomized controlled trial of a smoking cessation intervention for parents who smoke. Children had either a diagnosis of asthma (and an asthma emergency within the past 3 months) or were healthy (and had no medical conditions in the past 3 months). T...

What is the current status of trial NCT00862368?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 573 participants. The study started on 2005-10. Estimated completion is 2011-12.

What interventions are being tested in trial NCT00862368?

The interventions under investigation include: PAM (BEHAVIORAL), PAM-Enhanced/Asthma Counseling Phone Calls (BEHAVIORAL), Follow-Up Phone Calls - Child Wellness Topic (BEHAVIORAL).

Who is sponsoring clinical trial NCT00862368?

This trial is sponsored by The Miriam Hospital, which has 136 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.